Antares Pharma Company Description
Antares Pharma understands antagonism towards needles. The company develops needle-free systems for administering injectable drugs. Its Medi-Jector Vision system, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle. The Vision system is used primarily for the delivery of insulin and of human growth hormones; it is available over-the-counter and by prescription in the US and is also sold overseas. In addition to its needle-free systems, the company develops other drug delivery platforms, including topical gels, orally-administered disintegrating tablets, and mini-needle injection systems.
View the Comprehensive Company Description for Antares Pharma
The Company Description provides a historical perspective of Antares Pharma's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Antares Pharma's evolution in the marketplace.
